ConductScience.org, home

Paper393441

Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.

Zielinski C and 3 others. Clin Exp Immunol, 1979. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment. Papers, record 393441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393441

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zielinski CC
2Pehamberger HH
3Endler ATA T
4Knapp WW

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
LeukocytesMajor topic
Macrophage Migration-Inhibitory FactorsMajor topic
MelanomaMajor topic
Cell Movement
Chemotaxis, Leukocyte
Female
Humans
Male
Neoplasm Staging
Prognosis

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113872176The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.J Exp Med1962https://conductscience.org/library/papers/13872176PubMed
2362729[The influence of surgery upon leucocyte function (author's transl)].Wien Klin Wochenschr1978https://conductscience.org/library/papers/362729PubMed
3338223Serum-associated inhibition of leukotaxis in humans with cancer.Clin Immunol Immunopathol1978https://conductscience.org/library/papers/338223PubMed
4319243Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal.J Natl Cancer Inst1977https://conductscience.org/library/papers/319243PubMed
5716430[The influence of metabolic control on chemotactic activity in insulin-dependent diabetes mellitus (author's transl)].Wien Klin Wochenschr1978https://conductscience.org/library/papers/716430PubMed
6793477Immunotherapy of cancer in man: current status and prospectus.Ann N Y Acad Sci1976https://conductscience.org/library/papers/793477PubMed
7975640Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma.Clin Immunol Immunopathol1976https://conductscience.org/library/papers/975640PubMed
84855544Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.N Engl J Med1974https://conductscience.org/library/papers/4855544PubMed
94139220Chemotaxis of human polymorphonuclears in vitro. II. Technical study.J Immunol Methods1974https://conductscience.org/library/papers/4139220PubMed
104587141Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells.J Natl Cancer Inst1973https://conductscience.org/library/papers/4587141PubMed
114598018The modifying effect of BCG on the immunological induction of T cells.J Exp Med1974https://conductscience.org/library/papers/4598018PubMed
124826580Abnormal monocyte chemotactic response in cancer patients.J Natl Cancer Inst1974https://conductscience.org/library/papers/4826580PubMed
13769964The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis.Cancer Res1976https://conductscience.org/library/papers/769964PubMed
14766947Intralesional BCG in the treatment of metastatic malignant melanoma.Cancer1976https://conductscience.org/library/papers/766947PubMed
151244548Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.N Engl J Med1976https://conductscience.org/library/papers/1244548PubMed
165773814The histogenesis and biologic behavior of primary human malignant melanomas of the skin.Cancer Res1969https://conductscience.org/library/papers/5773814PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
6378240Divergent patterns of leucocyte locomotion in experimental post-traumatic osteomyelitis.Br J Exp Pathol1984https://conductscience.org/library/papers/6378240PubMed
2372992Modulation of leucocyte locomotion by interleukin-1.Clin Exp Immunol1990https://conductscience.org/library/papers/2372992PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/393441

GET https://conductscience.org/api/papers/v1/393441/authors